Replies to post #11738 on Innovus Pharmaceuticals Inc. (fka INNV)

[jtaylor68]

The ANDA is at the FDA. Makes sense, doesn't it?

With forward looking statements there can hardly be a lie. Compared to the duration it took the FDA to the approve the fluticasone ANDAs of competitors, Dr Damaj had all right to assume a response by the FDA was imminent. When will you understand this?

Likewise, it's not a lie to miss revenue guidance. It's very hard to make revenue projections for a company with a new product lineup as there is hardly any stable historical data to base projections on. If missing projection is a lie to you, you shouldn't even invest in fortune 500 companies. Missing revenue projections is part of the normal investment game.

[jtaylor68]

So is INNV, a real company, making real revenue from selling real products (which AVEO still doesn't do).
Look at the 7 year chart of AVEO until EMA approval. INNV's chart is a beauty in comparison.